Tolerability of omega-3 fatty acid supplements in perinatal women

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 3-4, 2007, Pages 203-208

  Freeman, Marlene P ^a,b   Sinha, Priti ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHAGIA; FATIGUE; FEMALE; HALITOSIS; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NAUSEA; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL;

DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS;

ZEA MAYS;

EID: 36248970148     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.09.004     Document Type: Article

References (45)

1. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54 (1991) 438-463
2. McGregor J.A., Allen J.G., Harris M.A., et al. The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes. Obstet. Gynecol. Surv. 56 (2001) S1-S13
3. Oken E., Wright R.O., Kleinman K.P., et al. Maternal fish consumption, hair mercury, and infant cognition in a US cohort. Environ. Health. Perspect. 113 (2005) 1376-1380
4. J.A. Dunstan, K. Simmer, G. Dixon, S.L.Prescott, Cognitive assessment at 21/2 years following fish oil supplementation in pregnancy: a randomized controlled trial, Arch. Dis. Child. Fetal Neonatal Ed., 2006 (Epub ahead of print).
5. Hibbeln J.R., Davis J.M., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369 (2007) 578-585
6. Judge M.P., Harel O., and Lammi-Keefe C.J. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am. J. Clin. Nutr. 85 (2007) 1572-1577
7. Araya J., Rojas M., Fernandez P., and Matenluna A. Essential fatty acid content of maternal erythrocyte phospholipids. A study in pertern and full-term human newborns. Rev. Med. Chil. 126 (1998) 391-396
8. Olsen S.F., Sorensen J.D., Secher N.J., et al. Randomised controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 339 (1992) 1003-1004
9. Smuts C.M., Huang M., Mundy D., Plasse T., Major S., and Carlson S.E. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet. Gynecol. 101 (2003) 469-479
10. Williams M.A., Zingham R.W., King I.B., and Zebelman A.M. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 6 (1995) 232-237
11. Petridou E., Koussouri M., Toupadaki N., et al. Diet during pregnancy and the risk of cerebral palsy. Br. J. Nutr. 79 (1998) 407-412
12. Foreman-Van Drongelen M., Van Houwelingen A.C., Kester A.D.M., Blanco C.E., Hasaart T.H.M., and Hornstra G. Influence of feeding artificial-formula milks containing docohexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status of healthy preterm infants. Br. J. Nutr. 76 (1996) 649-667
13. Hoffman D.R., and Uauy R. Essentiality of dietary n-3 fatty acids for premature infants: plasma and red blood cell fatty acid composition. Lipids 27 (1992) 886-895
14. SanGiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., and Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105 (2000) 1292-1298
15. Otto S.J., Van Houwelingen A.C., Antal M., et al. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur. J. Clin. Nutr. 51 (1997) 232-242
16. Holman R.T., Johnson S.B., and Ogburn P.L. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc. Natl. Acad. Sci. 88 (1991) 4835-4839
17. Al M.D., Van Houwelingen A.C., Kester A.D.M., Hasaart T.H.M., De Jong A.E.P., and Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 74 (1995) 55-68
18. Min Y., Ghebremeskel K., Crawford M.A., et al. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int. J. Vitam. Nutr. Res. 70 (2000) 70-75
19. Levant B., Radel J.D., and Carlson S.E. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids. Biol. Psychiatry 60 9 (2006) 987-990
20. Benisek D., Shabert J., and Skornik R. Dietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States. Obstet. Gynecol. 95 (2000) 77-78
21. 〈http://www.fda.gov/bbs/topics/news/2004/NEW01038.html〉.
22. Hites R.A., Foran J.A., Carpenter D.O., Hamilton M.C., Knuth B.A., and Schwager S.J. Global assessment of organic contaminants in farmed salmon. Science 303 (2004) 226-229
23. Oken E., Kleinman K.P., Berland W.E., Simon S.R., Rich-Edwards J.W., and Gillman M.W. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet. Gynecol. 102 (2003) 346-351
24. Foran S.E., Flood J.G., and Lewandrowski K.B. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?. Arch. Pathol. Lab. Med. 127 (2003) 1603-1605
25. Hilbert G., Lillemark L., Balchen S., and Hojskov C.S. Reduction of organochlorine contaminants from fish oil during refining. Chemosphere 37 (1998) 1241-1252
26. Ratings and recommendations on fish oil pills. Consumer Reports, 2003.
27. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry (American Psychiatric Association Subcommittee Report). J. Clin. Psychiatry 67 (2006) 1954-1967
28. Parker G., Gibson N.A., Brotchie H., Heruc G.L., Rees A.M., and Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J. Psychiatry 163 (2006) 969-978
29. R.K. McNamara, C.G. Hahn, R. Jandacek, et al., Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder, Biol. Psychiatry, 2006 (Epub ahead of print).
30. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69 (2002) 15-29
31. Otto S.J., de Groot R.H., and Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 237-243
32. Browne J.C., Scott K.M., and Silvers K.M. Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J. Affect. Disord. 90 (2006) 131-139
33. Llorente A.M., Jensen C.L., Voigt R.G., Fraley J.K., Berretta M.C., and Heird W.C. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstet. Gynecol. 188 (2003) 1348-1353
34. Freeman M.P., Hibbeln J.R., Wisner K.L., Brumbach B.H., Watchman W., and Gelenberg A.J. Randomized dose-ranging pilot trial of omega-3 fatty acids for postnatal depression. Acta Psychiatr. Scand. 113 (2006) 31-35
35. Freeman M.P., Hibbeln J.R., Wisner K.L., Watchman M., and Gelenberg A.J. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatr. 18 (2006) 21-24
36. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, fourth ed., American Psychiatric Association, Washington, DC, 1994.
37. Cox J.L., Holden J.M., and Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh postnatal depression scale. Br. J. Psychiatry (1987) 782-786
38. Genuis S.J., and Schwalfenberg G.K. Time for an oil check: the role of essential omega-3 fatty acids in maternal and pediatric health. J. Perinatol. 26 (2006) 359-365
39. Krauss-Etschmann S., Shadid S.R., Campoy C., et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am. J. Clin. Nutr. 85 (2007) 1392-1400
40. Lopez-Alarcon M., Bernabe-Garcia M., Del Prado M., et al. Docosahexaenoic acid administered in the acute phase protects the nutritional status of septic neonates. Nutrition 22 (2006) 731-737
41. Calvani M., Alessandri C., Sopo S.M., et al. Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy. Pediatr. Allergy Immunol. 17 (2006) 94-102
42. Carlson S.E. Docosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 6 (2001) 437-449
43. Hibbeln J.R., Ferguson T.A., and Blasbalg T.L. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int. Rev. Psychiatry 8 (2006) 107-118
44. McNamara R.K., and Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 329-349
45. Casper R.C. Nutrients, neurodevelopment, and mood. Curr. Psychiatry Rep. 6 (2004) 425-429